A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve
This research is looking at two different medicines, luspatercept and epoetin alfa, to treat a blood condition called myelodysplastic syndromes (MDS). People with MDS often have low red blood cell counts (anemia) and need regular blood transfusions. The main goal of this study is to find out if luspatercept is better than epoetin alfa at helping people become transfusion-independent, meaning they no longer need regular blood transfusions, and if it can also increase their red blood cell levels. The study focuses on people with specific types of MDS risk who haven't tried similar treatments before.
Em resumo
Resultados
Resultados deste estudo
Publicado June 2024Os resultados foram publicados para este estudo.
Sobre o que é este estudo?
You're reading about a research study for people with a blood condition called myelodysplastic syndromes, or MDS. MDS affects your bone marrow, which is the soft, spongy tissue inside your bones where new blood cells are made. In MDS, the bone marrow doesn't produce enough healthy blood cells, especially red blood cells. When you don't have enough healthy red blood cells, you can develop a condition called anemia, which can make you feel very tired and weak, and you might need regular blood transfusions.
This study is comparing two different medicines: luspatercept (sometimes called ACE-536) and epoetin alfa. Epoetin alfa is a common treatment that helps your body make more red blood cells. Luspatercept is a newer medicine, and researchers want to see if it works better than epoetin alfa. The main aim is to see if these medicines can help people with MDS stop needing blood transfusions for at least 12 weeks, and also increase their red blood cell count.
This is a 'Phase 3' study, which means it's one of the final steps in testing a new medicine to make sure it's both safe and effective before it can be widely used. Taking part in a study like this helps doctors learn more about the best ways to treat MDS, which can benefit many people in the future.
Pontos principais
- This study compares luspatercept and epoetin alfa for MDS.
- The main goal is to reduce the need for blood transfusions.
- It's a Phase 3 study, meaning it's a final step in testing a new medicine.
- You will receive regular check-ups and blood tests if you participate.
- Participation could help improve future treatments for MDS.
- You can stop participating at any time without affecting your care.
Quem pode ser elegível?
To join this study, doctors will first check if you have myelodysplastic syndromes (MDS) and if your condition is considered 'very low', 'low', or 'intermediate' risk. This is based on specific criteria that doctors use to classify MDS. An important part of joining is that you must be needing regular red blood cell transfusions. Specifically, you would have received between two and six units of blood every eight weeks for at least two months before the study starts. You also shouldn't have tried treatments like epoetin alfa before.
There are also some reasons why you might not be able to join. For example, if your anemia is caused by other easily treatable things like a lack of iron or vitamins, or if you have certain other serious health problems. You also wouldn't be able to join if you have a known history of acute myeloid leukaemia (AML) or if your blood pressure is not well controlled even with medication. The medical team will check all these carefully with you.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- I have been diagnosed with MDS.
- My MDS is classified as 'very low', 'low', or 'intermediate' risk.
- I currently need regular red blood cell transfusions (2-6 units every 8 weeks).
- I have not previously taken similar medications like epoetin alfa.
- I am generally well enough to participate in a study.
- My blood pressure is generally well-controlled.
O que envolve a participação?
If you decide to take part, you'll be assigned to receive either luspatercept or epoetin alfa. Neither you nor your doctor will get to choose which medicine you receive, and often you won't know which one it is (this is called a 'blinded' study). You'll have regular visits to the clinic for medical check-ups, blood tests, and to receive your study medicine. These visits will help the doctors monitor how you're doing, check your blood counts, and look for any side effects. The total duration of your participation in the study will depend on how you respond to the treatment and the study's design, but it will involve ongoing assessments and follow-up care.
Riscos e benefícios potenciais
Locations (226)
- Local Institution - 107Código postal verificadoBerkeley, Estados Unidos
- Local Institution - 115Código postal verificadoSan Diego, Estados Unidos
- Local Institution - 101Código postal verificadoWhittier, Estados Unidos
- Local Institution - 104Código postal verificadoNew Haven, Estados Unidos
- Local Institution - 136Código postal verificadoWashington D.C., Estados Unidos
- Local Institution - 119Código postal verificadoHudson, United States
- Local Institution - 120Código postal verificadoSão Petersburgo, Estados Unidos
- Local Institution - 122Código postal verificadoTallahassee, United States
- Local Institution - 108Código postal verificadoTampa, Estados Unidos
- Local Institution - 118Código postal verificadoWest Palm Beach, Estados Unidos
- Local Institution - 102Código postal verificadoPaducah, United States
- Local Institution - 123Código postal verificadoBethesda, Estados Unidos
Perguntas frequentes
What is MDS?
MDS (Myelodysplastic Syndromes) is a condition where your bone marrow doesn't make enough healthy blood cells, often leading to low red blood cell counts and anemia.
What does 'transfusion independence' mean?
It means you no longer need regular blood transfusions because your body is making enough red blood cells on its own, or with the help of medication.
Why can't I choose which medicine I get?
In studies like this, treatments are often given randomly, and sometimes neither you nor your doctor knows which medicine you are receiving. This helps ensure the study results are fair and unbiased.
E se eu experimentar efeitos colaterais?
The study team will closely monitor you for any side effects and will provide care and advice. You should always tell them about any new or worsening symptoms.
Posso sair do estudo a qualquer momento?
Yes, you have the right to withdraw from the study at any point, and this will not affect your future medical care.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.